Predictors of alternative medicine use by multiple sclerosis patients

Multiple Sclerosis

Volumn 9, Issue 5, 2003, Pages 461-466

  Marrie, Ruth Ann ^a   Hadjimichael, Olympia ^b   Vollmer, Timothy ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Alternative medicine; Cross sectional; Epidemiology; Multiple sclerosis; Predictors

Indexed keywords

BEE VENOM; MYELIN; PHOSPHATIDYLCHOLINE; PRIMROSE OIL; VITAMIN;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CHELATION THERAPY; CONTROLLED STUDY; CULTURAL FACTOR; DEMOGRAPHY; DIET THERAPY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIPULATIVE MEDICINE; MASSAGE; MULTIPLE SCLEROSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUTRITION; PREDICTION; PREVALENCE; SOCIAL ASPECT; UNITED STATES;

ADULT; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; REGISTRIES;

EID: 0142123567     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458503ms953oa     Document Type: Article

References (28)

1. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: Prevalence, costs and patterns of use. N Engl J Med 1993; 328: 246-52.
2. Astin J. Why patients use alternative medicine: Results of a national survey. JAMA 1998; 279: 1548-53.
3. Silverstein DD, Spiegel AD. Are physicians aware of the risks of alternative medicine. J Commun Health 2001; 26: 159-74.
4. Huntley A, Ernst E. Complementary and alternative therapies for treating multiple sclerosis symptoms: A systematic review. Compl Therap Med 2000; 8: 97-105.
5. Tremlett HL, Wiles CM, Luscombe DK. Nonprescription medicine use in a multiple sclerosis clinic population. Br J Pharmacol 2000; 50: 55-60.
6. Fisher AA, Le Couteur D. Lead poisoning from complementary and alternative medicine in multiple sclerosis. J Neurol Neurosurg Psychiat 2000; 69: 687-89.
7. Schwartz CE, Laitin E, Brotman S, LaRocca N. Utilization of unconventional treatments by persons with MS: Is it alternative or complementary? Neurology 1999; 52: 626-29.
8. Stenager E, Stenager EN, Knudsen L, Jensen K. The use of non-medical/alternative treatment in multiple sclerosis: A 5 year follow-up study. Acta Neurol Belg 1995; 95: 18-22.
9. Fawcett J, Sidney JS, Hanson MJS, Riley-Lawless K. Use of alternative health therapies by people with multiple sclerosis: An exploratory study. Hol Nurs Prac 1994; 8: 36-42.
10. Berkman CS, Pignotti MG, Cavallo PF, Holland NJ. Use of alternative treatments by people with multiple sclerosis. Neurorehabil Neural Repair 1999; 13: 243-54.
11. Bausell RB, Lee W-L, Berman BM. Demographic and health-related correlates of visits to complementary and alternative medical providers. Med Care 2001; 39: 190-96.
12. Consortium of Multiple Sclerosis Centers. NARCOMS Multiple Sclerosis Registry. 2002 http://www.mscare.org/narcoms
13. Schwartz CE, Vollmer T, Lee H, North American Research Consortium on Multiple Sclerosis Outcomes Study Group. Reliability and validity of two self-report measures of impairment and disability for MS. Neurology 1999; 52: 63-71.
14. US Government Census Bureau. United States Regions. 2002, www.census.gov/geo/www
15. Davies HTO, Crombie IK, Tavakoli M. When can odds ratios mislead? BMJ 1998; 316: 989-91.
16. SAS Institute Inc., Cary, NC: SAS.
17. Coleman LM, Fowler LL, Williams ME. Use of unproven therapies by people with Alzheimer's Disease. J Am Geriat Soc 1995; 43: 747-750.
18. Rajendran PM, Thompson RE, Reich SG. The use of alternative therapies by patients with Parkinson's disease. Neurology 2001; 57: 790-94.
19. Verhoef MJ, Hagen N, Pelletier G, Forsyth P. Alternative therapy use in neurologic diseases: Use in brain tumor patients. Neurology 1999; 52: 617-22.
20. Eisenberg DM, Davis RB, Ettner SL et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998; 280: 1569-75.
21. Messerer M, Johansson S-E, Wolk A. Sociodemographic and health behaviour factors among dietary supplement and natural remedy users. Eur J Clin Nutr 2001; 55: 1104-10.
22. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet 1996; 347: 569-73.
23. Millar WJ. Use of alternative health care practitioners by Canadians. Can J Public Health Rev Can Sante Publ 1997; 88: 154-58.
24. Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg DM. Alternative therapies used by women with breast cancer in four ethnic populations. J Nat Cancer Inst 2000; 92: 42-71.
25. Wolsko PM, Eisenberg DM, Davis RB, Ettner SL, Phillips RS. Insurance coverage, medical conditions, and visits to alternative medicine providers. Arch Inter Med 2002; 162: 281-87.
26. Kelner M, Wellman B. Who seeks alternative health care? A profile of the users of five modes of treatment. J Alter Complemen Med 1997; 3: 127-40.
27. Collins JG. Prevalence of selected chronic conditions, United States, 1986-1988. National Center for Health Statistics. Vital Health Stat 1993; 10: 1-94.
28. Paramore LC. Use of alternative therapies: Estimates from the 1994 Robert Wood Johnson Foundation National Access to Care Survey. J Pain Sympt Manage 1997; 13: 83-89.